Загрузка...
Luteinizing hormone-releasing hormone antagonists for urinary obstruction in prostate cancer
Luteinizing hormone-releasing hormone (LHRH) antagonists rapidly reduce testosterone and are preferred to LHRH agonists in situations when early response is important. The lack of flare reaction, as compared to LHRH agonists, is particularly desirable as it would not aggravate the problem. A 78-year...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Canadian Medical Association
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3886205/ https://ncbi.nlm.nih.gov/pubmed/24409216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.412 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|